Zobrazeno 1 - 10
of 243
pro vyhledávání: '"Gérald Raverot"'
Autor:
Mirela Diana Ilie, Alexandre Vasiljevic, Marie Chanal, Nicolas Gadot, Laura Chinezu, Emmanuel Jouanneau, Ana Hennino, Gérald Raverot, Philippe Bertolino
Publikováno v:
Acta Neuropathologica Communications, Vol 10, Iss 1, Pp 1-15 (2022)
Abstract Folliculostellate cells are S100B-expressing cells with numerous functions in the normal anterior pituitary. These cells have also been identified in pituitary neuroendocrine tumours (PitNETs), where their precise role remains elusive. Here,
Externí odkaz:
https://doaj.org/article/7feeb759dfbb42bf8853ff69fc12ba4a
Autor:
Laura Gerard, David Barthelemy, Arnaud Gauthier, Valerie Hervieu, Jonathan Lopez, Benjamin Gibert, Helene Lasolle, Laurence Chardon, Jessica Garcia, Gérald Raverot, Léa Payen, Thomas Walter
Publikováno v:
Endocrine Oncology, Vol 1, Iss 1, Pp K1-K6 (2023)
We report a case of metastatic pancreatic neuroendocrine carcinoma associated with paraneoplastic Cushing’s syndrome, successively treated with five lines of treatment (platin-etoposide, LV5FU2-dacarbazine, FOLFIRINOX, pembrolizumab, and paclitaxel
Externí odkaz:
https://doaj.org/article/c360988423ca4f5b97a7abac344f3ea5
Autor:
Hélène Lasolle, Mad-Hélénie Elsensohn, Anne Wierinckx, Eudeline Alix, Clément Bonnefille, Alexandre Vasiljevic, Christine Cortet, Bénédicte Decoudier, Nathalie Sturm, Stephan Gaillard, Amandine Ferrière, Pascal Roy, Emmanuel Jouanneau, Philippe Bertolino, Claire Bardel, Damien Sanlaville, Gérald Raverot
Publikováno v:
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-14 (2020)
Abstract The purpose of this study was to analyze the impact of copy number variations (CNV) on sporadic pituitary neuroendocrine tumors (PitNETs) prognosis, to identify specific prognosis markers according to the known clinico-pathological classific
Externí odkaz:
https://doaj.org/article/bad74d408c3644daa9aeac245f2ab195
Autor:
Solène Castellnou, Alexandre Vasiljevic, Véronique Lapras, Véronique Raverot, Eudeline Alix, Françoise Borson-Chazot, Emmanuel Jouanneau, Gérald Raverot, Hélène Lasolle
Publikováno v:
Endocrine Connections, Vol 9, Iss 3, Pp 243-253 (2020)
Objective: Somatostatin receptor type 5 (SST5) is inconsistently expressed by corticotroph tumors, with higher expression found in corticotropinomas havin g ubiquitin-specific protease 8 (USP8) mutations. Aims were to study the correlation between ch
Externí odkaz:
https://doaj.org/article/021de8faee9d4d7f94032fa417e26edd
Autor:
Thierry Brue, Philippe Chanson, Patrice Rodien, Brigitte Delemer, Delphine Drui, Lucile Marié, Laurène Juban, Lara Salvi, Robin Henocque, Gérald Raverot
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
ObjectiveEfficacy of pharmacological treatments for acromegaly has been assessed in many clinical or real-world studies but no study was interested in economics evaluation of these treatments in France. Therefore, the objective of this study was to e
Externí odkaz:
https://doaj.org/article/5c4b68987749411bbc7ec693382e94e6
Autor:
Mônica Gadelha, Marie Bex, Annamaria Colao, Elier Mitsael Pedroza García, Catalina Poiana, Marisela Jimenez-Sanchez, Serkan Yener, Rishav Mukherjee, Amy Bartalotta, Ricardo Maamari, Gérald Raverot
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2020)
Introduction: Acromegaly is a rare, serious endocrine disorder characterized by excess growth hormone (GH) secretion by a pituitary adenoma and overproduction of insulin-like growth factor I (IGF-I). Transsphenoidal surgery is the treatment of choice
Externí odkaz:
https://doaj.org/article/7eae9d3ca3464285ae2d01cf9405f65e
Autor:
Mathilde Peiffert, Christine Cugnet-Anceau, Stephane Dalle, Karim Chikh, Souad Assaad, Emmanuel Disse, Gérald Raverot, Françoise Borson-Chazot, Juliette Abeillon-du Payrat
Publikováno v:
Cancers, Vol 13, Iss 8, p 1944 (2021)
Thyrotoxicosis is an adverse event associated with immune checkpoint inhibitors (ICPis) that occurs in 0.6 to 3.2% of treated patients, depending on ICPi class. Presentation usually consists of a biphasic thyroiditis with transient thyrotoxicosis and
Externí odkaz:
https://doaj.org/article/7004c0196fd44e519f1eba75ee681ac5
Autor:
Anne Wierinckx, Etienne Delgrange, Philippe Bertolino, Patrick François, Philippe Chanson, Emmanuel Jouanneau, Joël Lachuer, Jacqueline Trouillas, Gérald Raverot
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Sex-related differences have been reported in various cancers, in particular men with lactotroph tumors have a worse prognosis than women. While the underlying mechanism of this sexual dimorphism remains unclear, it has been suggested that a lower es
Externí odkaz:
https://doaj.org/article/718ba2bd85d14e10847af69d01b2d8f3
Autor:
Manon Levy, Juliette Abeillon, Stéphane Dalle, Souad Assaad, Françoise Borson-Chazot, Emmanuel Disse, Gérald Raverot, Christine Cugnet-Anceau
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 10, p 3280 (2020)
Hypophysitis, secondary to programmed cell death 1 protein (PD1) and programmed cell death 1 ligand 1 (PDL1) inhibitors, were thought to be rare, with only a few studies describing more than one case with long-term follow-up. The aim of the present s
Externí odkaz:
https://doaj.org/article/d39ee09187f248cebd066a55d2ab2780
Autor:
Camille Duhamel, Mirela Diana Ilie, Henri Salle, Adjoa Sika Nassouri, Stephan Gaillard, Elise Deluche, Richard Assaker, Laurent Mortier, Christine Cortet, Gérald Raverot
Publikováno v:
Journal of Personalized Medicine, Vol 10, Iss 3, p 88 (2020)
Once temozolomide has failed, no other treatment is recommended for pituitary carcinomas and aggressive pituitary tumors. Recently, the use of immune checkpoint inhibitors (ICIs) has raised hope, but so far, only one corticotroph carcinoma and one ag
Externí odkaz:
https://doaj.org/article/9b4a083a706a45cd8a6bd1bab4253779